D.A. Davidson & Co’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$214K Sell
2,300
-337
-13% -$29.8K ﹤0.01% 1468
2025
Q4
$212K Hold
2,637
﹤0.01% 1444
2025
Q3
$257K Sell
2,637
-2,385
-47% -$192K ﹤0.01% 1353
2025
Q2
$350K Buy
5,022
+110
+2% +$6.28K ﹤0.01% 1177
2025
Q1
$244K Buy
4,912
+25
+0.5% +$1.58K ﹤0.01% 1257
2024
Q4
$341K Buy
+4,887
New +$406K ﹤0.01% 1165
2023
Q2
Sell
-3,100
Closed -$413K 1350
2023
Q1
$413K Sell
3,100
-700
-18% -$82.2K ﹤0.01% 950
2022
Q4
$302K Buy
3,800
+300
+9% +$21.1K ﹤0.01% 1040
2022
Q3
$212K Buy
+3,500
New +$226K ﹤0.01% 1146

Other funds holding ACLS

D.A. Davidson & Co's ACLS Position: Q1 2026 in Review

D.A. Davidson & Co reduced its Axcelis (ACLS) stake by 13% in Q1 2026, selling an estimated $29.8K and leaving 2,300 shares worth $214K. The position accounts for ﹤0.01% of the portfolio, ranked #1468.

D.A. Davidson & Co first reported a position in ACLS in Q3 2022 and has held it in 9 quarters since. The position peaked at $413K in Q1 2023. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • D.A. Davidson & Co held 2,300 shares of Axcelis worth $214K as of Q1 2026.
  • D.A. Davidson & Co sold 337 Axcelis shares in Q1 2026, an estimated $29.8K.
  • Axcelis made up ﹤0.01% of D.A. Davidson & Co's portfolio in Q1 2026, its #1468 holding.
  • D.A. Davidson & Co first reported a position in Axcelis in Q3 2022 and has held it in 9 quarters since.
  • D.A. Davidson & Co's Axcelis position peaked at $413K in Q1 2023.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on D.A. Davidson & Co's 13F filing for Q1 2026, filed 5 May 2026.